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Following allogeneic hematopoietic stem cell transplantation (HSCT), interferon (IFN)-γ lev-
els in the recipient’s body can strongly influence the clinical outcome. Human umbilical
cord-derived mesenchymal stem cells (UC-MSCs) are lucrative as biological tolerance-
inducers in HSCT settings. Hence, we studied the molecular mechanism of how UC-MSCs
influence natural killer (NK) cell-mediated IFN-γ production. Allogeneic NK cells were cul-
tured in direct contact with UC-MSCs or cell-free supernatants from mesenchymal stem
cell (MSC) cultures (MSC-conditioned media). We found that soluble factors secreted by
UC-MSCs strongly suppressed interleukin (IL)-12/IL-18-induced IFN-γ production by NK
cells by reducing phosphorylation of STAT4, NF-κB, as well as T-bet activity. UC-MSCs
secreted considerable amounts of activin-A, which could suppress IFN-γ production by
NK cells. Neutralization of activin-A in MSC-conditioned media significantly abrogated their
suppressive abilities.Till date, multiple groups have reported that prostaglandin (PG)-E2 pro-
duced by MSCs can suppress NK cell functions. Indeed, we found that inhibition of PGE2
production by MSCs could also significantly restore IFN-γ production. However, the effects
of activin-A and PGE2 were not cumulative. To the best of our knowledge, we are first to
report the role of activin-A in MSC-mediated suppression of IFN-γ production by NK cells.
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INTRODUCTION
Interferon (IFN)-γ is a pleiotropic cytokine that modulates a
diverse array of biological functions and is secreted by activated
T cells and natural killer (NK) cells (1). The effect of IFN-γ on
the outcome of hematopoietic stem cell transplantation (HSCT) is
divaricated and controversial. Some reports suggest that IFN-γ can
support graft vs. leukemia activity and prevent transplant rejec-
tion while others conclude that it can worsen graft vs. host disease
(GvHD) by boosting recipient T cell proliferation [as reviewed
in Ref. (2)]. In the early reconstitution phase following HSCT,
NK cells form the major population of lymphocytes (3). A mouse
model of allogeneic bone marrow transplantation (BMT) showed
that NK cell-derived IFN-γ can contribute to a heightened anti-
tumor activity by allografts (4). Thus, the ability of NK cells to
secrete levels of IFN-γ might significantly affect the clinical out-
come of a HSCT. Recently, interest is rising in using mesenchymal
stem cells (MSCs) to prevent GvHD, and facilitate engraftment in
HSCT due to their immunomodulatory nature. Co-transplanted
immunosuppressive MSCs might influence the transplantation
prognosis by modulating the levels of IFN-γ released by NK cells.
The majority of studies reporting on mechanistic clues behind
MSC-mediated inhibition of NK cells used bone marrow derived
(BM)-MSCs. Although BM-MSCs are commonly used in clinical
trials, umbilical cord-derived mesenchymal stem cells (UC-MSCs)
can prove to be more suitable source of transplantable MSCs due
to their high-proliferative potential, and ease of isolation (5). How-
ever, the molecular mechanism of how UC-MSCs affect the IFN-γ
producing capacity of NK cells is unknown and is investigated in
this study.
Mesenchymal stem cells isolated from bone marrow, tonsils,
muscles, and dental pulps are known to produce activin-A (6).
Activin-A is a transforming growth factor (TGF)-β superfamily
member, which can suppress IFN-γ production possibly by reduc-
tion of T-bet levels in NK cells (7). We found that UC-MSCs also
produce activin-A. Therefore, we investigated the contribution of
activin-A in suppression of NK cells. Furthermore, prostaglandin
(PG)-E2 produced by cyclooxygenase (COX)-2 activity in MSCs
have been shown to be important in inhibition of NK cell cytotox-
icity and proliferation (8, 9). In these studies, the mechanism of
IFN-γ suppression was not outlined. A study on induced pluripo-
tent stem (iPS) cell-derived MSCs reported that blocking of COX-2
failed to significantly restore interleukin (IL)-2-stimulated IFN-γ
production by MSC-pretreated NK cells (10). The enzyme COX-
1 is also able to release PGE2, and MSCs are known to express
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COX-1 (11). Noone et al. found that blocking COX-1 activity
in BM-MSCs can largely restore IL-2/IL-15 stimulated IFN-γ
production by NK cells (12). Therefore, we probed for the con-
tribution of COX-1/COX-2 in UC-MSC-mediated suppression of
IL-12/IL-18-induced IFN-γ production by NK cells.
MATERIALS AND METHODS
ISOLATION AND CULTURE OF UC-MSCs
This study was approved on 26th February, 2009 by the Institu-
tional Review Board (Project No. 3037) in an extended permission
# 443. With written consent, MSCs were isolated from human
umbilical cords obtained from full-term infants (38–40 gesta-
tion weeks) by explant culture, expanded and cryopreserved as
described elsewhere (13, 14). UC-MSCs were cultured in αMEM
supplemented with 10% human serum and 50µg/ml strepto-
mycin, 50 U/ml penicillin, 1 mM glutamine, and 0.5 mM sodium
pyruvate (Biochrom, Berlin, Germany). UC-MSCs were identi-
fied by high expression of CD73, CD90, and CD105 and lack
of CD14, CD19, CD34, CD45, and HLA-DR (15). The abil-
ity of the UC-MSCs to undergo chondrogenic, adipogenic, and
osteogenic differentiation was determined as described before
(data not shown) (16). Hence, the MSCs were found to fulfill all
the criteria recommended by the International Society for Cellular
Therapy (17).
ISOLATION OF NK CELLS FROM PERIPHERAL BLOOD MONONUCLEAR
CELLS
Heparinized blood samples obtained from healthy consenting
donors were diluted with an equal volume of phosphate buffered
saline (PBS). Peripheral blood mononuclear cells (PBMCs)
were separated by centrifugation over a ficoll-hypaque gradi-
ent and stained with anti-CD56 and CD3 antibodies. NK cells
(CD56+CD3− lymphocytes) were sorted using MoFlo Cell Sorter
(Beckman Coulter).
CELL CULTURE
Umbilical cord-derived mesenchymal stem cells were seeded in
24- or 48-well plates and allowed to adhere for 24 h. Subsequently,
freshly isolated allogeneic NK cells were added at a MSC:NK-
ratio of 1:10 and co-cultured for 16 h. Cell-free supernatants
from the NK-MSC co-cultures or MSC cultures without NK cells
were frozen to analyze the role of soluble factors as MSC-NK-
conditioned medium (NK-MSC cm) or MSC-conditioned media
(MSC cm), respectively. NK cells exposed to MSCs or different
conditioned media were collected, and tested for IFN-γ produc-
tion. NK cells cultured alone in unconditioned media were used
as controls. To induce IFN-γ production, NK cells were stimulated
with IL-12 (10 ng/ml) or IL-18 (10 ng/ml) alone or in combina-
tion. Brefeldin A (Sigma) was added after 1 h, and the incubation
was continued for 3 additional hours. IFN-γ production was ana-
lyzed by intracellular cytometric analysis. To neutralize activin-A,
follistatin (R&D Systems) was added to MSC cm at a final concen-
tration of 0.4µg/ml. To block PGE2 production, indomethacin
(R&D Systems) was added to MSC cultures at a concentration of
20µM. Cell-free supernatants were generated from these cultures
and are referred to as INDO-MSC cm. MSC cm was also collected
from the same MSCs as controls.
DETECTION OF PROTEINS USING FLOW CYTOMETRY
The following anti-human mAbs have been used: CD3 PE
(UCHT1) (Beckman Coulter), CD3 PerCP (SK7), CD11b PE
(ICRF44), CD14 APC (M5E2), CD56 PE (MY31), IFN-γ FITC
(B27), IL-12Rbeta1 PE (2.4E6), NFκB p65 PE (pS529), STAT4 PE
(38/p-STAT4) (BD Biosciences), CD56 APC (HCD56), T-bet PE
(4B10) (Biolegends), CD90 APC (5E10), IL-18Ralpha PE (H44)
(eBiosciences),HLA-DR FITC (AB3) (Dako),CD44 FITC (HI44a),
and CD105 FITC (MEM-226) (Immunotools). For detection of
IFN-γ, after surface staining with anti-CD3 and CD56, NK cells
were fixed with 4% paraformaldehyde (Merck) for 10 min at
room temperature. The cells were perforated in 0.1% saponin
buffer (PBS supplemented with 0.1% saponin (Riedel-de-Haën)
and 0.01 M HEPES (Roth), and fluorochrome-tagged antibodies
against IFN-γ or T-bet were added. After 30 min of incubation
and three washes, cells were analyzed by flow cytometry. Each flow
cytometric analysis was controlled with isotype-matched mAbs.
For detection of phosphorylated NF-κB p65 and STAT4
(pSTAT4), NK cells were stimulated with IL-12 and IL-18 for
15 min, washed and fixed immediately with 4% paraformalde-
hyde and BD Lyse/Fix Buffer 1×, respectively. pSTAT was detected
using BD Phosflow anti-STAT4 antibody after permeabilizing the
cells with BD Perm Buffer III, according to manufacturer’s proto-
col. Phosphorylated NF-κB p65 was detected with BD Phosflow
anti-NF-κB p65 antibody after permeabilizing the cells with 0.1%
saponin buffer as described previously. All flow cytometry-based
experiments were performed on FACS Calibur using Cell-Quest
Pro Software. Offline data analyses were done on Summit 5.1
software (Beckman Coulter).
ACTIVIN-A ENZYME-LINKED IMMUNOSORBENT ASSAY
Activin-A was measured in culture supernatants by sandwich
enzyme-linked immunosorbent assay (ELISA) technique using a
commercially available ELISA kit (R&D Systems), according to the
manufacturer’s protocol. Concentrations were calculated by com-
parison with known activin-A standards using a free five parameter
logistic curve fitting program1.
T-bet DNA-BINDING ELISA
NK-92 cells were expanded in presence of 200 IU/ml of IL-2 fol-
lowed by IL-2 deprivation for 2 days. The cells were cultured for
additional 16 h, with or without MSC cm, and subsequently stim-
ulated with IL-12 (10 ng/ml) and IL-18 (10 ng/ml) in fresh media.
Nuclear proteins from NK-92 cells were extracted using a commer-
cially available protein extraction kit (Nuclear Extract Kit, Active
Motif) according to the manufacturer’s protocol. The amount of
protein was quantitated using the Coomassie (Bradford) Protein
Assay. The protein yield was between 0.1 and 0.15 mg at 2–3 mg/ml
from 107 NK-92 cells. The nuclear proteins were added to a
96-well plate coated with oligonucleotide containing T-bet con-
sensus binding site (TransAM T-bet, Active Motif). At this step,
the activated T-bet present in the nuclear extracts is expected to
bind to the oligonucleotides coated on the plate. Bound T-bet
was subsequently detected using anti T-bet ELISA, according to
manufacturer’s protocol.
1http://www.readerfit.com
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STATISTICAL ANALYSES
We performed paired two-tailed t -tests or ANOVA with Bonfer-
roni post-test (to compare more than two groups) using GRAPH-
PAD PRISM V5.00 Software. Levels of significance are shown as p-
values (*p< 0.05, **p< 0.01, ***p< 0.001). Bar graphs represent
mean± SEM.
RESULTS
MSC-INDUCED SUPPRESSION OF IFN-γ PRODUCTION IN NK CELLS
Natural killer cells were cultured with or without MSCs for
16 h and stimulated with IL-12 and IL-18 for 4 h. A significant
reduction in the IFN-γ production was observed in NK cells
pre-cultured with MSCs compared to NK cells cultured alone
(Figure 1A, representative dot plots). Next, we investigated if the
suppressive effect of MSCs is maintained under prolonged stimu-
lation by IL-12 and IL-18. We activated NK cells, pre-cultured in
the presence or absence of MSCs, with IL-12 and IL-18 for 18 h
instead of 4. As shown in Figure 1B, NK cells pre-cultured with
MSCs exhibited significant suppression even after prolonged stim-
ulation. However, the suppression was not as potent as observed in
the 4 h stimulation protocol. We further investigated if the MSCs
caused the NK cells to be less responsive to stimulation by IL-12
or IL-18 or the combination of the two. We found that NK cells
exposed to MSCs became significantly less responsive when used
alone or in combination (Figure 1C). To ascertain the role of
soluble factors in the observed immunosuppression, we cultured
NK cells overnight in cell-free supernatants from MSC cultures
and NK-MSC co-cultures. We found that both supernatants were
similarly potent in suppressing IFN-γ production by NK cells
(Figure 1D).
MSC-MEDIATED INHIBITION OF IL-12 AND IL-18 RECEPTOR SIGNALING
IN NK CELLS
Our results suggested that MSCs inhibited the responsiveness of
NK cells to IL-12 and IL-18 using some soluble factors. Hence, we
examined if MSC secreted factors affected the expression of IL-12
and IL-18 receptors (IL-12R and IL-18R, respectively) on the NK
cells. Following overnight culture in MSC cm or normal media,
the expression of IL-12R beta1 and IL-18R alpha was analyzed on
NK cells. CD56dim NK cells showed higher expression of IL-12R
compared to CD56bright cells (Figure 2A). MSC cm was found to
have no effect on IL-12R expression levels on NK cells (Figure 2B).
Almost all NK cells stained positive for IL-18R (Figure 2C) and
treatment with MSC cm did not alter IL-18R expression on NK
FIGURE 1 | Suppression of IFN-γ production by NK cells. (A) NK cells
cultured overnight with or without MSCs were stimulated with IL-12 and
IL-18 in culture for 4 h. Brefeldin A was added after 1 h of culture. Cells
were surface and intracellularly stained, followed by flow cytometry-based
analysis of IFN-γ production (n=6). The dot plot depicts IFN-γ+ NK cells
from one representative experiment. (B) NK cells cultured overnight with
or without MSCs were stimulated with IL-12 and IL-18 in culture for 18 h.
The bar graphs represent the percentage of IFN-γ producing NK cells
(n=4). (C) NK cells were cultured with or without MSCs, and their IFN-γ
producing ability in response to IL-12 alone, or IL-18 alone, or to the
combination of IL-18 and IL-12 was measured (n= 4). (D) NK cells were
cultured in MSC-conditioned media or NK-MSC-conditioned media, and
their IFN-γ producing ability in response to IL-12 and IL-18 was measured
(n=4).
www.frontiersin.org December 2014 | Volume 5 | Article 662 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chatterjee et al. MSC-mediated NK cell interferon-γ suppression
FIGURE 2 | Effect of UC-MSCs on IL-12 and IL-18 receptor signaling in NK
cells. (A–D) NK cells were cultured in normal media or MSC cm. NK cells
were washed, IL-12R and IL-18R expression was analyzed. The dot plots depict
the levels of IL-12R (A) and IL-18R (C) on normal NK cells. The bar graphs
represent the percentage of IL-12R+ [(B); n=5] and IL18R+ [(D); n=5] NK
cells cultured with or without MSC cm. (E,F) NK cells were cultured in normal
media or MSC cm, followed by stimulation with IL-12 and IL-18 to induce
phosphorylation events downstream of IL-12R and IL-18R activation (n=3).
Intracellular levels of pSTAT (E) and activated NF-κB (F) was measured in the
NK cells.
cells (Figure 2D). Next, we examined if MSC cm affected the
downstream signaling of these receptors without affecting their
surface expression. Phosphorylation of STAT4 and NF-κB p65 are
commonly reported signaling events associated with the activa-
tion IL-12R and IL-18R, respectively (18–20). Following overnight
culture in MSC cm or normal media, we stimulated the NK cells
with IL-12 and IL-18 for 15 min. Upon analyzing the intracellular
levels of pSTAT4 and activated NF-κB in the NK cells, we found
that MSC cm could significantly abrogate both IL-12R and IL-18R
downstream signaling. Pre-treatment with MSC cm significantly
reduced pSTAT4 and activated NF-κB content of IL-12 and IL-18
stimulated NK cells (Figures 2E,F; Figure S2 in Supplementary
Material).
CO-CULTURE WITH UC-MSC INDUCES DOWNREGULATION OF T-bet IN
NK CELLS
The transcription factor T-bet is the master regulator of IFN-γ
production in T cells and NK cells (21). We found a significant
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FIGURE 3 | Effect of UC-MSCs onT-bet activity in NK cells.
(A) NK cells cultured with or without MSCs were harvested and
stained for intracellular T-bet (n=4). (B) NK cells cultured with or
without MSCs were harvested, stimulated with IL-12 and IL-18 for 4 h
and stained for intracellular T-bet (n=5) (C) NK cells were cultured in
MSC-conditioned media (MSC cm) or normal media for 16 h and
stained for intracellular T-bet (n=3). (D) NK-92 cells were expanded in
presence of IL-2 and subsequently cultured without IL-2 for 2 days. The
NK-92 cells were collected, washed, and cultured for 16 h with MSC
cm or without MSC cm. The nuclear proteins from NK-92 cells were
extracted, quantitated, and frozen. The amount of activated T-bet
present was detected using T-bet DNA-binding ELISA with a standard
colorimetric read-out. The graph represents the corrected OD 450
values of each sample multiplied by a factor of 100 (n=4).
decrease of basal T-bet levels in NK cells following co-culture
with MSC compared to control NK cells cultured without MSCs
(Figure 3A). When the NK cells were removed from the MSCs
after overnight co-culture and then stimulated with IL-12 and
IL-18, the difference in T-bet levels in NK cells cultured with or
without MSCs was still maintained (Figure 3B). Similar decrease
in T-bet levels was also seen in NK cells cultured with MSC cm
(Figure 3C). We further examined if the exposure to MSC cm
lowers the DNA-binding activity of T-bet in NK cells by nuclear
protein isolation (containing activated T-bet) followed by T-bet
DNA-binding ELISA. Since it is difficult to obtain large number
of NK cells from peripheral blood, we used NK-92 cells instead
of primary NK cells. Our experiments had so far focused on NK
cell-MSC interaction in absence of any stimulatory cytokine while
the NK-92 cells are normally expanded in presence of IL-2. These
cells were therefore deprived of IL-2 for 2 days and then cultured
for 16 h with or without MSC cm. The cells were then stimulated
with IL-12 and IL-18 for 4 h. We first examined if this protocol
resulted in a decrease of IFN-γ production NK-92 cells cultured
in MSC cm. Indeed, the IL-2 deprived NK-92 cells are susceptible
to the suppressive effect of MSC cm. MSC cm-treated NK-92 cells
produced considerably less IFN-γ upon IL-12/IL-18 stimulation
compared to NK-92 cells cultured in normal media (Figure S1 in
Supplementary Material). Next, we proceeded to test for changes
in T-bet DNA-binding activity. The IL-2 deprived NK-92 cells were
cultured for 16 h with or without MSC cm. This was followed by
stimulation with IL-12 and IL-18 for 4 h to activate T-bet and allow
its nuclear translocation. Nuclear proteins were extracted from
NK-92 cells and the extent of T-bet activation was assayed using
DNA-binding ELISA. We observed that pre-treatment of NK-92
cells with MSC cm significantly reduced the T-bet activation levels
compared to cells cultured without MSC cm (Figure 3D).
MECHANISM OF IFN-γ SUPPRESSION
Activin-A has been described to suppress IFN-γ production, with-
out affecting NK cells’ perforin or granzyme content, possibly by
reduction of T-bet levels in NK cells (7). MSC cm or NK-MSC cm
was found to have no effect on the perforin or granzyme contents
of NK cells (data not shown). Thus, we hypothesized that activin-A
could be one of the molecules secreted by UC-MSC, which is crit-
ical for the observed inhibition of IFN-γ production by NK cells.
Using a sandwich ELISA, we could demonstrate that UC-MSCs
secreted activin-A constitutively. Upon exposure to NK cells, there
was an increase in the release of activin-A. However, this increase
did not reach significance (Figure 4A). Addition of activin-A to
NK cell cultures could significantly reduce their IFN-γ produc-
ing ability in response IL-12/IL-18 (Figure 4B). Follistatin is an
activin-binding protein that can neutralize the bioactivity of the
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FIGURE 4 | Role of activin-A and PGE2. (A) Using a sandwich ELISA, the
amount of activin-A secreted by MSCs when cultured alone (MSC cm) or in
presence of NK cells (NK-MSC cm) was evaluated (n=4). (B) NK cells were
stimulated with IL-12 and IL-18 in presence or absence of 50 ng/ml activin-A.
Brefeldin A was added after 1 h of culture. Following 4 h of stimulation, the
cells were stained for intracellular IFN-γ expression and analyzed by flow
cytometry for IFN-γ production (n=4). (C) NK cells were cultured in MSC cm
in presence or absence of follistatin (Fol). NK cells were stimulated with IL-12
and IL-18 for 4 h and stained for intracellular IFN-γ (n=7). (D) NK cells were
cultured in MSC-conditioned media (MSC cm) or MSC cm generated in
presence of indomethacin (INDO-MSC cm). The NK cells were stimulated
with IL-12 and IL-18 for 4 h and stained for intracellular IFN-γ (n=4).
latter (22). We added follistatin in MSC cm to neutralize activin-A.
NK cells cultured in activin-A-neutralized MSC cm were signifi-
cantly better at IFN-γ production compared to NK cells cultured
in MSC cm (Figure 4C). This indicates that activin-A neutral-
ization can abrogate the suppressive potential of MSC cm. We
also blocked COX-2 activity in NK cell-MSC co-cultures using a
pharmacological inhibitor (NS-398). COX-2 inhibition could not
abolish MSC-induced suppression of IFN-γ production (Figure
S3 in Supplementary Material). Recently, Noone et al. found that
pharmacological blocking of COX-1 could alleviate BM-MSC-
induced suppression of IFN-γproduction by NK cells. To verify the
role of COX-1 in UC-MSC-mediated suppression, we generated
conditioned media from UC-MSC cultures in presence of COX-1
blocker, indomethacin (INDO-MSC cm). MSC cm was collected
as control. Fresh NK cells were cultured in MSC cm or INDO-
MSC cm for 16 h. The NK cells were then washed and stimulated
with IL-12 and IL-18 for 4 h to induce IFN-γ production. Blocking
PGE2 release using indomethacin could significantly restore NK
cell IFN-γ production (Figure 4D). However, simultaneous block-
ing of activin-A and PGE2 failed to show additive effects (Figure
S4 in Supplementary Material).
DISCUSSION
The inclination toward using MSCs for cell therapy is on the rise,
and BM-MSCs have been shown to be useful for the treatment and
prevention of GvHD, as well as facilitation of engraftment follow-
ing HSCT in several clinical trials (23). The anti-inflammatory
effect of MSCs, that helps control GvHD, is possibly mediated
by the suppression of T cell proliferation (24). Following HSCT,
the first lymphocyte population to reconstitute are NK cells and
they can eliminate recipient leukemic cells which leads to signif-
icantly reduced rates of leukemia relapse (25) without causing
GvHD. MSCs co-administered with HSC to suppress T cells are
also likely to suppress NK cell functions, thereby eliminating their
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beneficial effects. Detailed understanding of MSC-immune system
interaction is a prerequisite to efficient use of MSCs as biological
immunosuppressant.
We found that NK cells pre-cultured with UC-MSCs exhibit
significant deficit in their ability to secrete IFN-γ upon stimula-
tion with IL-12 and IL-18 compared to NK cells cultured without
MSCs. We observed that MSC cm could effectively suppress IFN-γ
production. This indicated that some soluble factor, which damp-
ens the IFN-γ synthesizing machinery, is secreted by the MSCs
in large amounts even before coming in contact with NK cells.
However, these factors did not affect IL-12 and IL-18 receptor
expression on NK cells. Instead, MSC cm significantly reduced
phosphorylation of signaling intermediates downstream of IL-12
and IL-18 receptor ligation by corresponding ligands. Previous
exposure to MSC cm affected phosphorylation of STAT4 and NF-
κB. We found significant decrease of basal T-bet levels in NK cells
after being co-cultured in direct contact with MSC or MSC cm
compared to control NK cells cultured in normal media. This
reduction in T-bet was maintained in these NK cells even after
stimulation with IL-12 and IL-18. The biological activity of a tran-
scription factor largely depends on its ability to bind to DNA
in order to activate transcription. Therefore, it was important
to know if soluble factors from MSCs could regulate the DNA-
binding ability of T-bet in NK cells. IL-2 deprived NK-92 cells were
used instead of NK cells to study the DNA-binding activity of T-
bet. We found that pre-exposure to MSC cm considerably reduced
the ability of NK-92 cells to activate T-bet when subsequently
exposed to IL-12 and IL-18. T-bet is one of the most important
regulators of IFN-γ promoter activity. Hence, the observed defect
in T-bet activation could possibly explain the significant reduction
in IFN-γ production by NK cells when exposed to MSC derived
soluble suppressants.
Activin-A has been described to suppress IFN-γ production by
NK cells along with a decrease in T-bet levels without affecting NK
cell cytotoxicity (7). UC-MSCs were found to produce consider-
able amounts of activin-A. Treatment of NK cells with activin-A
inhibited their IFN-γ producing potential. Blocking activin-A in
MSC cm using follistatin abrogated MSC cm-mediated suppres-
sion, and produced significant increase in percentage of IFN-γ
producing NK cells. In our experimental settings, blocking PGE2
release using the selective COX-2 blocker had failed to restore
IFN-γ production by NK cells. However, indomethacin mediated
blocking could successfully alleviate MSC-induced suppression of
IFN-γ production by NK cells. Indomethacin is a universal COX
inhibitor but is relatively selective for COX-1. These results imply
that COX-1-derived PGE2 is sufficient to suppress NK cell IFN-γ
production. This explains why the blocking of PGE2 production
by COX-2 alone (using NS-398) was ineffective in our culture
conditions. This can also possibly explain why Giuliani et al. were
unsuccessful in abrogating PGE2 mediated suppression using NS-
398 (10). Our hypothesis seeks to resolve the controversy about
the involvement of PGE2 in suppression of IFN-γ production.
Our observations, thus, identify activin-A as yet another “partner
in crime” in the growing list of strategies used by MSCs to suppress
our immune system. These results indicate that UC-MSCs utilize
activin-A as well as PGE2 (derived mainly from COX-1 activity)
to reduce IFN-γ production by NK cells.
Although UC is an excellent source of MSCs (26) and several
clinical trials using UC-MSCs are underway2, BM-MSCs are still
the gold-standard for cell therapy (13, 27). Activin-A has been
shown to be released by BM-MSCs as well as MSCs derived from
tonsils, muscles, and dental pulps (6). Therefore, our findings
might extend to the immunosuppression mediated by other MSC
populations, including clinically relevant BM-MSCs. However,
this remains to be investigated. Understanding the commonalities
in the immunosuppression exerted by different MSC populations
can help us stream-line our efforts toward improved MSC-based
cell-therapies in future.
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